Macrophage activation syndrome in childhood rheumatic diseases

Angelo Ravelli, Alejandra Pringe, Clara Malattia, Ilaria Sala, Alberto Martini

Research output: Contribution to journalArticle

Abstract

Macrophage activation syndrome (MAS) is a life-threatening complication of systemic inflammatory disorders that is thought to be caused by the activation and uncontrolled proliferation of T lymphocytes and macrophages, leading to widespread hemophagocytosis and cytokine overproduction. Recent findings in hemophagocytic lymphohistiocytosis, a disease that is clinically very similar to MAS, highlight the possible pathogenetic role of a defective function of cytotoxic lymphocytes. Prompt diagnosis is important and recently preliminary diagnostic guidelines for the syndrome have been proposed. The recognition that MAS belongs to the secondary or reactive hemophagocytic syndromes has led to propose to rename it according to the contemporary classification of histiocytic disorders. Cyclosporine A has been found to be effective in patients with corticosteroid resistant MAS.

Original languageEnglish
Pages (from-to)225-230
Number of pages6
JournalCurrent Rheumatology Reviews
Volume3
Issue number3
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Macrophage Activation Syndrome
Rheumatic Diseases
Hemophagocytic Lymphohistiocytosis
Cyclosporine
Adrenal Cortex Hormones
Macrophages
Guidelines
Lymphocytes
Cytokines
T-Lymphocytes

Keywords

  • Hemophagocytic lymphohistiocytosis
  • Hemophagocytic syndrome
  • Macrophage activation syndrome
  • Systemic juvenile idiopathic arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Macrophage activation syndrome in childhood rheumatic diseases. / Ravelli, Angelo; Pringe, Alejandra; Malattia, Clara; Sala, Ilaria; Martini, Alberto.

In: Current Rheumatology Reviews, Vol. 3, No. 3, 08.2007, p. 225-230.

Research output: Contribution to journalArticle

@article{14ef3825f4004a059007587c9df60af5,
title = "Macrophage activation syndrome in childhood rheumatic diseases",
abstract = "Macrophage activation syndrome (MAS) is a life-threatening complication of systemic inflammatory disorders that is thought to be caused by the activation and uncontrolled proliferation of T lymphocytes and macrophages, leading to widespread hemophagocytosis and cytokine overproduction. Recent findings in hemophagocytic lymphohistiocytosis, a disease that is clinically very similar to MAS, highlight the possible pathogenetic role of a defective function of cytotoxic lymphocytes. Prompt diagnosis is important and recently preliminary diagnostic guidelines for the syndrome have been proposed. The recognition that MAS belongs to the secondary or reactive hemophagocytic syndromes has led to propose to rename it according to the contemporary classification of histiocytic disorders. Cyclosporine A has been found to be effective in patients with corticosteroid resistant MAS.",
keywords = "Hemophagocytic lymphohistiocytosis, Hemophagocytic syndrome, Macrophage activation syndrome, Systemic juvenile idiopathic arthritis",
author = "Angelo Ravelli and Alejandra Pringe and Clara Malattia and Ilaria Sala and Alberto Martini",
year = "2007",
month = "8",
doi = "10.2174/157339707781387617",
language = "English",
volume = "3",
pages = "225--230",
journal = "Current Rheumatology Reviews",
issn = "1573-3971",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Macrophage activation syndrome in childhood rheumatic diseases

AU - Ravelli, Angelo

AU - Pringe, Alejandra

AU - Malattia, Clara

AU - Sala, Ilaria

AU - Martini, Alberto

PY - 2007/8

Y1 - 2007/8

N2 - Macrophage activation syndrome (MAS) is a life-threatening complication of systemic inflammatory disorders that is thought to be caused by the activation and uncontrolled proliferation of T lymphocytes and macrophages, leading to widespread hemophagocytosis and cytokine overproduction. Recent findings in hemophagocytic lymphohistiocytosis, a disease that is clinically very similar to MAS, highlight the possible pathogenetic role of a defective function of cytotoxic lymphocytes. Prompt diagnosis is important and recently preliminary diagnostic guidelines for the syndrome have been proposed. The recognition that MAS belongs to the secondary or reactive hemophagocytic syndromes has led to propose to rename it according to the contemporary classification of histiocytic disorders. Cyclosporine A has been found to be effective in patients with corticosteroid resistant MAS.

AB - Macrophage activation syndrome (MAS) is a life-threatening complication of systemic inflammatory disorders that is thought to be caused by the activation and uncontrolled proliferation of T lymphocytes and macrophages, leading to widespread hemophagocytosis and cytokine overproduction. Recent findings in hemophagocytic lymphohistiocytosis, a disease that is clinically very similar to MAS, highlight the possible pathogenetic role of a defective function of cytotoxic lymphocytes. Prompt diagnosis is important and recently preliminary diagnostic guidelines for the syndrome have been proposed. The recognition that MAS belongs to the secondary or reactive hemophagocytic syndromes has led to propose to rename it according to the contemporary classification of histiocytic disorders. Cyclosporine A has been found to be effective in patients with corticosteroid resistant MAS.

KW - Hemophagocytic lymphohistiocytosis

KW - Hemophagocytic syndrome

KW - Macrophage activation syndrome

KW - Systemic juvenile idiopathic arthritis

UR - http://www.scopus.com/inward/record.url?scp=34548363286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548363286&partnerID=8YFLogxK

U2 - 10.2174/157339707781387617

DO - 10.2174/157339707781387617

M3 - Article

VL - 3

SP - 225

EP - 230

JO - Current Rheumatology Reviews

JF - Current Rheumatology Reviews

SN - 1573-3971

IS - 3

ER -